Should Cefoxitin Non-Susceptibility in Ceftriaxone-Susceptible E. coli and K. pneumoniae Prompt Concerns Regarding Plasmid-Mediated AmpC Resistance? A Genomic Characterization and Summary of Treatment Challenges in Singapore
Authors:
- Jonathan Jinpeng FooJFJonathan Jinpeng Foo
- Ying Ying OngYOYing Ying Ong
- Clement Kin Ming TsuiCTClement Kin Ming Tsui
- David C. LyeDLDavid C. Lye
- De Partha PratimDPDe Partha Pratim
- Nurhidayah Binte Mohamed YazidNYNurhidayah Binte Mohamed Yazid
- Swaine L. ChenSCSwaine L. Chen
- Shawn VasooSVShawn Vasoo
- Tat Ming NgTNTat Ming Ng
Open Access
- 18 July 2025
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 14 (7) , 722
Abstract
Objectives: Plasmid-mediated AmpC beta-lactamases represent a growing clinical concern in Enterobacterales, with challenges in diagnostic approaches, limited data on clinical outcomes, and our incomplete understanding of their regulatory mechanisms warranting the need for further investigation. Methods: This retrospective study examined the genomic and clinical characteristics of cefoxitin-non-susceptible, ceftriaxone-susceptible Escherichia coli and Klebsiella pneumoniae bloodstream isolates collected from a tertiary hospital in Singapore. Whole-genome sequencing was performed to detect ampC genes, subtypes, and associated regulatory elements. Results: Among 108 cefoxitin-non-susceptible isolates, only 15 (13.9%) harboured plasmid-mediated ampC, suggesting that cefoxitin non-susceptibility alone in ceftriaxone susceptible isolates was not predictive of ampC carriage. All plasmid-ampC isolates were from the blaDHA-1 subtype and carried ampR, a known transcriptional regulator of inducible beta-lactamase expression. Notably, five non-ampC carrying Klebsiella isolates displayed truncations in ompK35 and ompK36, which could potentially contribute to reduced cefoxitin susceptibility via porin loss. Conclusions: These findings underscore the limited diagnostic utility of cefoxitin susceptibility testing for detecting plasmid-mediated ampC producers and highlight the clinical relevance of regulatory genes such as ampR in mediating inducible resistance. The routine incorporation of molecular diagnostics or genome sequencing may be necessary to improve detection accuracy and inform antimicrobial stewardship strategies.Keywords
Funding Information
- National Medical Research Council under the Research Innovation Enterprise 2020 Collaborative Centre Grant Seed Funding Programme (CCGSFP19003)
This publication has 24 references indexed in Scilit:
- Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative InfectionsClinical Infectious Diseases, 2024
- Antimicrobial resistance: Impacts, challenges, and future prospectsJournal of Medicine, Surgery, and Public Health, 2024
- β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substratesRSC Medicinal Chemistry, 2021
- AmpC β-lactamase-producing Enterobacterales: what a clinician should knowInfection, 2019
- A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant WorldClinical Infectious Diseases, 2019
- The β-Lactamase Gene Regulator AmpR Is a Tetramer That Recognizes and Binds the d-Ala-d-Ala Motif of Its Repressor UDP-N-acetylmuramic Acid (MurNAc)-pentapeptideJournal of Biological Chemistry, 2015
- QUAST: quality assessment tool for genome assembliesBioinformatics, 2013
- SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell SequencingJournal of Computational Biology, 2012
- Transferable DHA-1 cephalosporinase in Escherichia coliInternational Journal of Antimicrobial Agents, 2006
- Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli.The EMBO Journal, 1986